You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KROS Award Disclosure
Prener Anne · SEC Form 4 · Filed Jul 6, 2026
Award
Calculated transaction value
$0
Prener Anne Director
KROS
Keros Therapeutics
KROS
Transaction date
Jul 1, 2026
Public filing date
Jul 6, 2026
Filing lag
Filed 5 days later
KROS daily price context
Close on/before transaction
$10.88
Jul 1, 2026
First close after public filing
$11.65
Jul 7, 2026
30-day return after filing
-14.21%
Through Aug 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 13,786 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001797917-26-000007
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Keros Therapeutics, Inc. KROS Current | Award | Jul 1, 2026 | $0 |
| Keros Therapeutics, Inc. KROS | Award | Jul 1, 2026 | $0 |